Atlas Trials

Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment

Clinical trial NCT02982603 · COMPLETED

Trial details

NCT number
NCT02982603
Sponsor
Dongzhimen Hospital, Beijing
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Mild Cognitive ImpairmentHerbal Medicine Allergy
Start date
2015-05-01
Primary completion
2017-12-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.